BioSpace News Archive

Within a six-week period, Grady Memorial Hospital eye specialist Dr. Yousuf Khalifa witnessed an unusual set of traumatic eye injuries.

The Janssen Pharmaceutical Companies of Johnson & Johnson is delighted with the recent announcement from the World Health Organisation (WHO) to include abiraterone acetate (ZYTIGA®) for the treatment of metastatic castration-resistant prostate cancer (mCRPC), in the updated Essential Medicines List, published on 9th July 2019

Samsung Bioepis Co., Ltd. today announced that the European Medicines Agency (EMA) has accepted for review the company’s Marketing Authorization Application (MAA) for SB8, a biosimilar candidate referencing AVASTIN® i (bevacizumab).

High incidence of chronic diseases globally and the need for personalized medicine, has encouraged several technological advancements in the form of recombinant DNA that involves genetic combinations of species to treat diseases.

Health Canada is aware that Pfizer Canada is reporting that a shortage of its 0.3 mg format EpiPen auto-injector may lead to temporary supply constraints in the coming months. EpiPen Jr (0.15 mg) is not affected by this shortage.

Trillium Community Health Plan (Trillium) is pleased to announce the appointment of Christopher Hummer as the new CEO of Trillium and Health Net of Oregon, effective August 12, 2019.

The number of women using cannabis in the year before they get pregnant and early in their pregnancies is increasing, and their frequency of use is also rising, according to new data from Kaiser Permanente.

Pfizer Canada is reporting that, while there has been stable supply of EpiPen auto-injectors in Canada in 2019 to date, a shortage of its 0.3 mg format EpiPen auto-injector may lead to temporary supply constraints in the coming months. EpiPen Jr (0.15 mg) is not affected by this shortage.

The costs and timelines to conduct clinical trials continue to increase, as does study complexity.

The NRP Group, a vertically-integrated, best-in-class developer, builder and manager of multifamily housing, today announced it will partner with The MetroHealth System and CCH Development Corp. to develop a mixed-use community in Cleveland’s Clark-Fulton neighborhood.